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To compare the survival among patients with chronic kidney disease who had optimal starts
of renal replacement therapy, dialysis or hemodialysis, with patients who had suboptimal
starts.
Methods
A retrospective cohort consisting of >18 year-old patients who started renal replacement
therapy, using peritoneal dialysis or hemodialysis, in any public hospital or associated center
of the Andalusian Public Health System, between the 1st of January of 2006 and the 15th of
March of 2017. The optimal start was defined when all the following criteria were met: a
planned dialysis start, a minimum of six-month follow-up by a nephrologist, and a first dialy-
sis method coinciding with the one registered at 90 days. The information was obtained from
the registry of the Information System of the Transplant Autonomic Coordination of
Andalusia.
Results
A total of 10,692 patients were studied. 4,377 (40.9%) of these patients died. A total of
4,937 patients (46.17%) achieved optimal starts of renal replacement therapy and showed
higher survival rates (HR 0.669; 95% CI 0.628–0.712) in the multivariate analysis of Cox
regression model.
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Conclusions
Patients with an optimal start of renal replacement therapy have a greater survival than
those who had a non-optimal start. Therefore, the necessary measures should be encour-
aged to increase the optimal start of the patient in dialysis.
Introduction
Chronic kidney disease (CKD) is a major public health concern associated with increased mor-
tality and significant costs for the health system and for society. Thus, the cost associated with
the care of this population amounts to 2.5% of the total health budget, although these patients
represent <0.1% of the population [1,2]. This cost refers only to renal replacement therapy
(RRT). The consumption of healthcare resources of patients with CKD on a global scale
(approximately the 10% of the adult population) [3] is not well-known. In recent years there
has been an increase in the prevalence of diabetes and the elderly population, which, along
with other causes, is causing an increase in the number of patients with CKD [4,5]. In addition,
it has been estimated that there is about 20% of the patients without diagnosis, and this propor-
tion rises to 35–40% when it comes to patients with high prevalence diseases, such as hyperten-
sion or diabetes mellitus [6].
The literature describes that, in order to obtain the maximum benefit or the optimal benefit
from the RRT, a timely referral to the nephrologist, timely preparation and initiation in dialysis
is required [7]. A Cochrane review concludes that patients with CKD and late referrals to the
nephrologist show a higher use of temporary catheters and emergency dialysis. On the con-
trary, these patients show a lower use of peritoneal dialysis and the anticipated transplant as a
starting method. In addition, these patients experience higher rates of hospitalizations, more
days of admission, and impose higher costs. On the other hand, it has been described that the
type of vascular access in those treated with hemodialysis has an influence on the survival of
the patient [8,9]. Taking into account the heavy burden of the disease, as a consequence of the
high social and economic costs of RRT, priority attention is required to improve the care of
these patients. In the light of this, the objective of this article is to compare the survival among
patients who had optimal starts of RRT with patients who had suboptimal starts.
Materials and methods
Design
A retrospective cohort study.
Study population
Patients included in the SICATA registry: adults (>18 years old) who started RRT in any hos-
pital or associated center of the Andalusian Public Health System (APHS), in the modality of
peritoneal dialysis (PD) or hemodialysis (HD), between the 1st of January of 2006 and the 15th
of March of 2017 (date of data extraction).
Exclusion criteria
Patients whose first option of treatment was the anticipated renal transplant (N = 339);
patients treated by domiciliary HD (N = 20); patients who recovered renal function at some
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point of the monitoring (N = 251); patients treated at some point outside Andalusia and who
subsequently returned to the APHS (N = 61); patients with indication of PD (ultrafiltration)
for a refractory heart failure (N = 10); or patients who had more than two changes of dialysis
therapy (N = 184).
Variables to study
The dependent variable was the optimal start, which was defined by a consensus of experts as
the simultaneous fulfillment of the following premises: definitive access to dialysis, planned
dialysis start, a minimum of six-month follow-up by a nephrologist, and a first dialysis method
coinciding with the one registered at 90 days. The failure to comply with any of these criteria
was classified as suboptimal start. In addition, the following independent variables were
considered:
1. Sociodemographic variables: sex, age at treatment initiation, employment status, place born
and province of start of RRT.
2. Clinical variables: date of treatment start, Charlson index at the beginning of RRT, primary
renal disease and exitus.
Process
The information was extracted from the Basic Module of the Chronic Renal Insufficiency
(CRI) Subsystem of the Information System of the Transplant Autonomic Coordination of
Andalusia (SICATA) [5], which is a public and compulsory registry of patients in RRT in
Andalusia. Inclusion in this registry requires duly signed informed consent. The extracted
information did not include identifiable data of the patient, following the European Union
regulations on personal data protection. All professionals participating in the study signed a
commitment of data confidentiality and an ethical commitment.
Measurement instruments
The Charlson Comorbidity Index began to be registered in the CRI module from the year
2006 and it is collected at the beginning of the first RRT. Therefrom, 19 medical situations that
are pondered between 1 and 6 can be obtained.
Statistical analysis
A descriptive analysis of the variables was carried out with the most commonly used statistics:
proportions and percentages, for the categorical variables, and averages and standard devia-
tions for the continuous variables. First, an analysis was performed to describe the differences
between optimal and suboptimal starts. For this purpose, the qualitative variables were con-
trasted using the chi-squared test, and the quantitative variables using the logistic regression
model. Subsequently, a bivariate survival analysis was performed through the Kaplan-Meier
method and using the log-rank test for comparison. The survival time was defined as from the
start in RRT until the death of the patient or censoring. The proportional hazards assumption
was verified using the Schoenfeld Test. The statistical significance was defined as error proba-
bility α (5%) and 95% confidence intervals (95% CI). Finally, a Cox regression model was con-
structed with the independent variables that were shown statistically different survival. All
statistical analyses were performed with Stata v13.
Optimal start in dialysis increases patient survival
PLOS ONE | https://doi.org/10.1371/journal.pone.0219037 July 30, 2019 3 / 10
Results
After applying the exclusion criteria, the cohort was composed of 10,692 patients, of which
4,937 (46.17%) patients achieved optimal starts and 5,755 (53.83%) achieved suboptimal starts.
A total of 4,377 (40.9%) of the patients died during the monitoring, with a median survival
time of 6.25 years (95% CI 6.06–6.51). Fig 1 shows the survival function of the total number of
patients included in this study. Fig 2 shows the survival curve according to the optimal start.
The median survival for patients with optimal start was 7.79 years (95% CI 7.29–8.22) and 4.98
years (95% CI 4.70–5.25) for patients with suboptimal start.
At a bivariate level, statistically significant differences were observed between patients who
achieved optimal and suboptimal starts in the variables of employment status (p<0.001), place
born (p<0.001), diabetes (p<0.001), primary renal disease (p<0.001), exitus (p<0.001) and
Charlson Comorbidity Index (p<0.001) (Table 1).
In terms of survival, at a bivariate level, a better survival was found associated with being a
woman, underage, with active employment status, lower score in the Charlson Index and not
having a diabetes diagnosis (p<0.001) (Table 1).
Patients with optimal start of RRT showed greater survival than those with suboptimal start
(HR 0.635; 95% CI 0.598–0.674). Thus, in the multivariate model, when adjusting by the rest
of the variables, this risk was (HR 0.669; 95% CI 0.628–0.712). Another variable significantly
associated with greater survival in the multivariate model was having an active employment
status (HR 0.626; 95% CI 0.545–0.719). On the contrary, the variables associated with worse
survival rates were having diabetes (HR 1.191; 95% CI 1.100–1.289), an older age (HR 1.030;
95% CI 1.026–1.034), higher Charlson Index scores (HR 1.178; 95% CI 1.157–1.200) at
Fig 1. Survival function of the total number of patients included in the study.
https://doi.org/10.1371/journal.pone.0219037.g001
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treatment initiation, and having Tubulointerstitial Disease (HR 1.320; 95% CI 1.128–1.544),
Systemic Disease (HR 1.448; 95% CI 1.266–1.655) or others (HR 1.206; 95% CI 1.053–1.382) as
primary renal disease (Table 2).
Discussion
This study compares the survival of patients who started RRT with a planned peritoneal dialy-
sis or hemodialysis, with a definitive dialysis access, a minimum of six-month follow-up by a
nephrologist, and a first dialysis method coinciding with the one registered at 90 days (all indi-
cators of optimal start), with patients who did not comply with the criteria (suboptimal start).
Thus, the analyses performed show that patients who achieved an optimal start in dialysis
have, on average, a survival rate of 2.8 years higher than patients who had a suboptimal start.
This difference has been shown to be statistically significant.
The proportion of patients who achieved an optimal start of RRT is within the range of val-
ues described in the literature [10–17]. In this sense, the literature provides heterogeneous con-
siderations of what is the optimal start of the patient in dialysis means. However, most
definitions associate the concept with a planned start. This paper provides a wider (though at
the same time restrictive) definition of what it is an optimal start, as a result of the consensus
reached by the working team which includes nephrologists. This definition integrates other
requirements such as the coincidence in the registry of the treatment at 90 days. It would have
been interesting to incorporate as a requirement the training and information of the patient
on the available options for RRT [18–20]. Unfortunately, the database did not enable the iden-
tification or assessment of the training received by the patient. This training improves patients’
Fig 2. Survival function according to the optimal start in RRT.
https://doi.org/10.1371/journal.pone.0219037.g002
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adherence to recommendations and healthy habits. Thus, a systematic review of the educa-
tional interventions for patients with CKD states that the educational interventions can
improve the results of the patient, both those informed by them (quality of life) and others of a
clinical nature (estimated glomerular filtration rate, survival, etc.) [21]. In addition, it must be
taken into consideration that patients at the beginning of RRT feel an important socioemo-
tional and psychological burden, so this training offers them tools to obtain answers to this
need [22], as well as helping them in the decision-making process and comprehension of the
treatment options.
Patients who have a suboptimal start of RRT have a lower probability of being included in
the waiting list for a renal transplant and a lower probability of starting treatment with PD
[23]. In addition, it must be taken into consideration that patients who started PD show a
higher probability of receiving renal transplantation. It is important to bear in mind that the
benefits of receiving renal transplantation, in terms of survival, are greater, and this should be
taken into consideration in the interpretation of the results.
On the other hand, cases in which patients, in the course of their disease, start dialysis late,
or have an unexpected renal deterioration leading to an urgent start, are examples of






Sex Male 3,125 (63.3%) 3.547 (61.63%)
Female 1,812 (36.70%) 2,208 (38.37%) 0.077 0.914 (0.859–0.972)
Employment status Not active 2,530 (51.25%) 2,997 (52.08%)
Active 512 (10.37%) 855 (14.86%) 0.333 (0.293–0.378)
Lost 1,895 (38.38%) 1,903 (33.07%) <0.001 0.869 (0.811–0.932)
Place born Spain 4,327 (87.84%) 5,239 (91.11%)
Rest of Europe 121 (2.46%) 93 (1.62%) 1.173 (0.945–1.457)
Africa 139 (2.82%) 69 (1.20%) 0.374 (0.269–0.519)
America 78 (1.58%) 55 (0.96%) 0.370 (0.243–0.563)
Asia/Oceania/ Lost 261 (5.30%) 294 (5.11%) <0.001 1.092 (0.967–1.235)
Diabetes Yes 2,014 (40.79%) 1.962 (34.09%)
No 2,923 (59.21%) 3,793 (65.91%) <0.001 0.639 (0.602–0.679)
Primary renal disease Glomerular Disease 556 (11.26%) 591 (10.28%)
Tubulointerstitial Dis. 445 (9.01%) 607 (10.56%) 1.554 (0.331–1.815)
Systemic Disease 2,243 (45.43%) 2,380 (41.39%) 2.032 (1.787–2.310)
Familial Nephropathies 201 (4.07%) 668 (11.62%) 0.810 (0.667–0.983)
Other 1,492 (30.22%) 1,504 (26.16%) <0.001 1.656 (1.449–1.893)
Exitus Live 2,610 (52.87%) 3,705 (64.38%)






Age at treatment initiation (years) 63.07 63.16 0.208� 1.040 (1.037–1.043)
Charlson Comorbidity Index 5.95 5.36 <0.001� 1.223 (1.209–1.237)
�Mann-Whitney test
† chi2 differences between optimal and suboptimal start
ACKD: advanced chronic kidney disease; HD: hemodialysis; PD: peritoneal dialysis
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suboptimal starts and have negative consequences on their well-being and quality of life. This
hampers the adequate selection of patients for the RRT since a “shared decision making” is not
possible and can significantly influence the percentage of use of the different dialysis modali-
ties and the probability for renal transplantation. In addition, these conditions make antici-
pated renal transplant impossible and hinders the inclusion in the waiting list at an
appropriate time.
According to the health technology assessment report carried out in Spain, the cost of the
planned-start is approximately € 3,300 cheaper than the urgent-start. In the literature these fig-
ures increase up to $ 13,200 [24].
Table 2. Crude and adjusted hazard ratios of Cox regression models of the optimal start (n = 10,671).
Crude Model p HR (95%CI)�
Optimal Start Suboptimal
Optimal <0.001 0.635 (0.598–0.674)
Adjusted Model� p HR (95%CI)�
Optimal Start Suboptimal
Optimal <0.001 0.669 (0.628–0.712)
Sex Male
Female 0.331 0.969 (0.910–1.032)
Start Method HD
PD 0.244 0.934 (0.834–1.047)
Place born Spain
Rest of Europe 0.015 1.311 (1.053–1.634)
Africa 0.032 0.695 (0.499–0.968)
America 0.029 0.625 (0.410–0.953)
Asia/Oceania/ Lost <0.001 1.297 (1.138–1.478)
Province of start of the RRT P1
P2 0.637 1.025 (0.924–1.136)
P3 0.109 1.087 (0.981–1.205)
P4 0.110 1.102 (0.978–1.242)
P5 0.001 1.233 (1.092–1.391)
P6 <0.001 1.374 (1.206–1.565)
P7 0.313 1.070 (0.937–1.221)
P8 <0.001 1.319 (1.149–1.515)
No data 0.009 1.221 (1.050–1.420)
Employment status Not active
Active <0.001 0.626 (0.545–0.719)
Lost 0.012 0.901 (0.813–0.977)
Primary renal disease Glomerular Disease
Tubulointerstitial Disease 0.001 1.320 (1.128–1.544)
Systemic Disease <0.001 1.448 (1.266–1.655)
Familial Nephropathies 0.095 0.846 (0.696–1.029)
Other 0.007 1.206 (1.053–1.382)
Diabetes No
Yes <0.001 1.191 (1.100–1.289)
Age at treatment initiation (years) <0.001 1.030 (1.026–1.034)
Charlson Comorbidity Index <0.001 1.178 (1.157–1.200)
ACKD: advanced chronic kidney disease; HD: hemodialysis; PD: peritoneal dialysis
� HR (95%CI): hazard ratio (95% confidence interval)
https://doi.org/10.1371/journal.pone.0219037.t002
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In light of the above, it would be desirable and necessary to increase the resources allocated
to primary care of patients with CKD. This will be key to implement educational interventions
(training programs in risk assessment and management) to delay the progression of the disease
and reduce late referrals to nephrologists, among others. In hospitals settings, there is a need
for specialized consultations provided by a multidisciplinary team (at least a nephrologist, spe-
cialized nursing and structured programs for patient education and training), for patients with
advanced chronic kidney disease (ACKD) [25,26]. These and other measures are key to pro-
mote an increase in the percentage of patients achieving an optimal start in dialysis, according
to the results of this work and taking into consideration the high clinical and economic impact
on patients and on the health system.
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